Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Heart Rate Variability and Medication Adherence in Resistant Hypertension

This single-center, cross-sectional observational study examines the relationship between adherence to antihypertensive therapy - verified objectively by therapeutic drug monitoring (TDM) - and heart rate variability (HRV) in patients with resistant hypertension. Patients are recruited opportunistically, in a nurse-led manner, in a one-day-care cardiology unit, and undergo a single examination: a short-term HRV recording (Polar H10), a single blood draw for antihypertensive drug levels, office blood pressure, and self-completed questionnaires. There is no follow-up.

Participants needed: 150
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Nemocnice AGEL Trinec-Podlesi a.s.Updated: Jul 16, 2026Locations: 1
Eligibility criteria

Age 18-75 years with diagnosed essential hypertension [+3]

Absence of sinus rhythm: atrial fibrillation/flutter, ventricular arrhythmias, h... [+3]

Status: Not yet recruiting

CT Body Composition as Predictor of Exercise Therapy Outcome in Peripheral Arterial Disease

Supervised exercise therapy (SET) is the recommended first treatment for patients with leg artery disease (peripheral arterial disease, PAD) causing pain when walking. However, approximately 40% of patients do not benefit meaningfully and go on to require a procedure to open the blocked arteries within three months. This study investigates whether body composition measurements - specifically the quality of muscle and the amount of belly fat - taken from a CT scan already performed as part of routine care, can identify before treatment begins which patients are unlikely to respond to exercise therapy. If confirmed, this approach would allow doctors to use information from a scan patients are already having, with no additional tests, to better match patients to the right treatment from the start.

Participants needed: 128
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Nemocnice AGEL Trinec-Podlesi a.s.Updated: Feb 25, 2026
Eligibility criteria

Age 18 years or older [+5]

Fontaine stage III or IV peripheral arterial disease (rest pain or tissue loss;... [+5]